Cart
sales@molnova.com
SPI--112Me
CAS No. 1243685-62-2
SPI--112Me( —— )
Catalog No. M19354 CAS No. 1243685-62-2
SPI--112Me
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 117 | In Stock |
|
| 5MG | 86 | In Stock |
|
| 10MG | 125 | In Stock |
|
| 25MG | 217 | In Stock |
|
| 50MG | 335 | In Stock |
|
| 100MG | 502 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSPI--112Me
-
NoteResearch use only, not for human use.
-
Brief DescriptionSPI--112Me
-
DescriptionSPI--112Me
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetmTOR
-
RecptorPTPase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1243685-62-2
-
Formula Weight482.48
-
Molecular FormulaC23H19FN4O5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFc1ccc(cc1)CNS(=O)(=O)C2=CC=4C(C=C2)=NC(=O)C=4NNc3cc(ccc3)C(=O)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
WYE-125132
A potent, specific, ATP-competitive and orally active mTOR inhibitor with IC50 of 0.19 nM.
-
Cbz-B3A
Cbz-B3A is a potent inhibitor of mTORC1 signalling, inhibits phosphorylation of eIF4E-binding protein 1 (4EBP1) and blocks translation by 68%.
-
Seco Rapamycin sodiu...
Seco-rapamycin is the first in vivo open-ring metabolite of rapamycin that does not affect mTOR.
